Research & Development

Research at Apotex includes the development of generic, biosimilar and innovative pharmaceuticals.

New products have been a critical component of Apotex's growth and are central to fulfilling our company’s purpose and have resulted in the development of substantial expertise in formulation development, synthetic and analytical chemistry.

Apotex has invested over $1 billion over the past ten years to develop innovative product solutions in various categories. Apotex stands among the Top 100 in Canada’s corporate R&D spending.

Clinical Studies Contact Information

Apotex Inc. no longer conducts clinical studies on site in Canada.

If you have any questions about or participated in previous clinical studies at 465 Garyray Drive please contact us by email